Hepatitis

This information sheet discusses extrahepatic manifestation, which means diseases or conditions that affect organs other than the liver when someone has hepatitis C virus (HCV). It explains how extrahepatic manifestations of hepatitis C can be found in the skin, eyes, joints, immune system, nervous system and kidneys. The fact sheet provides a list of these conditions and states that some of these conditions are more common and well-documented, while others are infrequent or their association with hepatitis C has not yet been proven.

This information sheet discusses why it is important to abstain from alcohol after being diagnosed with with hepatitis C virus (HCV), especially for patients undergoing antiviral therapy. It states that patients who drink during HCV treatment are less likely to clear the virus. The fact sheet gives tips to check for alcohol abuse and has a table with information on different types of liquor.

This information sheet focuses on tips for reading and understanding an abstract, which can be very challenging for most people. It states that there are usually seven pieces to an abstract, then breaks them down and gives hints on how to understand them. It includes a copy of an abstract to illustrate how to go through each section. The fact sheet is geared toward people with hepatitis.

This information sheet explains that the number of Hispanics with hepatitis C (2.6%) is higher than the number of people with hepatitis C in the general population (1.3%). It also states that hepatitis C disease progression has been shown to be faster in Hispanics than in non-Hispanic whites. The fact sheet describes treatment of hepatitis C, which has been found to be as effective in Hispanics as it is in other groups.

This information sheet presents facts about viral hepatitis in tabular format. It discusses hepatitis A, B, and C. It lists statistics; routes of transmission; persons at risk; incubation period; symptoms of acute infection; the likelihood of symptomatic acute infection; the potential for chronic infection; the severity; serologic tests for acute and chronic infection; screening recommendations for chronic infection; treatment; vaccination recommendations and schedule, if any; and testing recommendations.

This information sheet provides general information about Hepatitis C. It explains that Hepatitis C is an infection of the liver caused by the Hepatitis C virus. The information sheet discusses the effect of Hepatitis C, acute and chronic forms of the disease, transmission, epidemiology, the seriousness of the disease, symptoms, diagnostic tests and who should be tested, treatment, and how people with Hepatitis C can take care of their liver. This information sheet is also available in B&W at: http://www.cdc.gov/hepatitis/HCV/PDFs/HepCGeneralFactSheet-BW.pdf.

This information sheet provides general information about Hepatitis C. It explains that Hepatitis C is an infection of the liver caused by the Hepatitis C virus. The information sheet discusses the effect of Hepatitis C, acute and chronic forms of the disease, transmission, epidemiology, the seriousness of the disease, symptoms, diagnostic tests and who should be tested, treatment, and how people with Hepatitis C can take care of their liver. This information sheet is also available in B&W at: http://www.cdc.gov/hepatitis/HCV/PDFs/HepCGeneralFactSheet-BW_sp.pdf.

This report discusses the hepatitis C virus (HCV), how it is treated, and how it can be prevented. The report examines the epidemiology of HCV. It discusses the screening tests, history, general treatment, and postexposure prophylaxis for HCV. The report explains the ways that HCV can be transmitted from person to person and how the virus can be spread through bodily fluid. It identifies the most serious high risk behaviors such as injection drug use and certain sexual practices. The report cites the risks associated with health care work.

This report updates CDC's Advisory Committee on Immunization Practices' (ACIP) 1996 recommendations on the prevention of hepatitis A through immunization (MMWR 1996;45[RR-15].) and includes (1) new data about the epidemiology of hepatitis A; (2) recent findings about the effectiveness of community-based hepatitis A vaccination programs; and (3) recommendations for the routine vaccination of children in states, counties, and communities with rates that are twice the 1987-1997 national average or greater and consideration of routine vaccination of children in states, counties, and communities wi

This report updates previous US Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that may contain Hepatitis B, Hepatitis C, or HIV/AIDS. It contains recommendations for Hepatitis B Virus postexposure management including initiation of hepatitis B vaccine series to any susceptible, unvaccinated person who sustains blood or body fluid exposure. Guidance is provided to clinicians and exposed HCP for selecting the appropriate HBV postexposure prophylaxis (PEP).